Zinc Acetylcysteinate

Zinc acetylcysteinate is a chelated compound combining zinc with N-acetylcysteine (NAC), designed to deliver both minerals and thiol-based antioxidant activity simultaneously. Its primary mechanism involves NAC's free sulfhydryl group scavenging reactive oxygen species while zinc supports over 300 enzymatic processes including superoxide dismutase activity.

Origin & History

Zinc acetylcysteine is a coordination complex combining N-acetylcysteine (NAC) with zinc in a 2:1 molar ratio, with the molecular formula C₁₀H₁₆N₂O₆S₂Zn. It is classified as an organic compound belonging to n-acyl-L-alpha-amino acids and functions as both a free radical scavenger and metal cation complex. The compound is currently listed as investigational in DrugBank, indicating it has not completed standard clinical development.

Historical & Cultural Context

No information about traditional or historical use of zinc acetylcysteine was found in the available research. The compound appears to be a modern pharmaceutical development without documented traditional medicine applications.

Health Benefits

• Antioxidant activity through free radical scavenging, though limited by NAC's higher pKa (Evidence: Mechanistic data only)
• Metal chelation properties that may prevent toxic metal binding to proteins (Evidence: Theoretical based on NAC properties)
• Protection against reactive aldehydes through Michael adduct formation (Evidence: In vitro mechanisms described)
• Potential enhanced bioavailability compared to standard NAC due to zinc coordination (Evidence: Bioavailability score of 1, but no comparative studies)
• May offer electrophile conjugation protecting cells from quinones and epoxides (Evidence: Mechanistic understanding only)

How It Works

Zinc acetylcysteinate dissociates in biological environments to release zinc ions and N-acetylcysteine, with NAC's free thiol (-SH) group directly scavenging reactive oxygen species including hydroxyl radicals and hypochlorous acid. The NAC moiety also serves as a precursor to glutathione synthesis by supplying cysteine, the rate-limiting substrate for gamma-glutamylcysteine synthetase. Zinc itself acts as a cofactor for copper-zinc superoxide dismutase (Cu-Zn SOD), catalyzing the dismutation of superoxide radicals (O2−) to hydrogen peroxide, while also stabilizing protein structures through tetrahedral coordination with cysteine and histidine residues.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses were found for zinc acetylcysteine in the provided research. The compound is classified as investigational in DrugBank, suggesting it has not completed standard clinical development pathways. While extensive clinical literature exists for N-acetylcysteine alone, the zinc-complexed form lacks published human efficacy studies.

Clinical Summary

No clinical trials have been conducted specifically on zinc acetylcysteinate as a distinct compound; available evidence is extrapolated from separate research on zinc and NAC individually. NAC has been studied in randomized controlled trials at doses of 600–1800 mg/day showing benefits in conditions like chronic obstructive pulmonary disease and acetaminophen toxicity, while zinc supplementation trials typically use 15–40 mg/day elemental zinc. The combination's theoretical synergy in metal chelation and antioxidant defense remains mechanistically plausible but unvalidated in human subjects. Current evidence rating is mechanistic and theoretical, meaning clinicians cannot make dosing or efficacy recommendations specific to this chelated form.

Nutritional Profile

Zinc Acetylcysteinate is a coordination compound combining zinc (Zn²⁺) with N-acetylcysteine (NAC) as the ligand. Elemental zinc content: approximately 18-22% by molecular weight (theoretical ~20% based on molecular formula ZnC₄H₇NO₃S, MW ~230 g/mol). Sulfur content: approximately 13-14% by weight from the acetylcysteine moiety. No macronutrient contribution (carbohydrates, fats, or protein in nutritional sense). Micronutrient delivery: zinc is delivered as a chelated mineral form, with each mole providing one mole of bioavailable zinc (RDA reference: 8-11mg elemental zinc/day for adults). Bioactive compounds: the NAC ligand (N-acetylcysteine component) contributes a thiol (-SH) group with a pKa of ~9.5, limiting free radical scavenging efficiency at physiological pH (~7.4), though the thioether-zinc coordination may partially modulate this. Acetyl group accounts for approximately 18% molecular weight. Bioavailability notes: chelated zinc forms generally demonstrate superior intestinal absorption compared to inorganic zinc salts (zinc oxide, zinc sulfate), estimated 40-60% absorption efficiency vs. 20-30% for inorganic forms, though specific human bioavailability data for this exact compound is limited to theoretical extrapolation from comparable zinc amino acid chelates. No fiber, vitamin, or significant caloric content.

Preparation & Dosage

No clinically studied dosage ranges have been established for zinc acetylcysteine. The investigational status of this compound indicates that standardized dosing protocols have not been determined through clinical trials. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

N-acetylcysteine, zinc picolinate, vitamin C, selenium, glutathione

Safety & Interactions

N-acetylcysteine at standard doses (600–1800 mg/day) is generally well tolerated but can cause nausea, vomiting, and gastrointestinal upset, particularly on an empty stomach; the zinc component may add risk of nausea at doses exceeding 40 mg elemental zinc daily. Zinc can reduce absorption of antibiotics including tetracyclines and fluoroquinolones and may interfere with copper absorption when used chronically above 40 mg/day elemental zinc. NAC may potentiate the effects of nitroglycerin and other nitrate medications, and caution is warranted in individuals taking anticoagulants due to theoretical thiol-mediated effects on platelet function. Pregnancy safety for this specific chelate is unestablished; while both zinc and NAC have been studied individually in pregnancy, the combination compound lacks gestational safety data and should be avoided without medical supervision.